This is a non-core endpoint: only basic statistics are computed.
Defects in post-translational modification of lysosomal enzymes
E4_LYSOPOSTTRANS
No definition available.
Endpoint definition
↥429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
16
Check minimum number of events None
16
Include endpoints None
16
Remove individuals based on genotype QC
16
Control definitions
Extra metadata
Not enough data for upset plot.
Or the full data table
Similar endpoints
↥List of similar endpoints to Defects in post-translational modification of lysosomal enzymes based on the number of shared cases.
Broader endpoints:
- Disorders of glycoprotein metabolism
- Metabolic disorders
- Endocrine, nutritional and metabolic diseases
- Diseases of the musculoskeletal system and connective tissue
- Any reimbursement code in KELA
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 16 | 11 | 5 |
Unadjusted prevalence (%) | 0.00 | 0.00 | 0.00 |
Mean age at first event (years) | 53.10 | 50.34 | 59.17 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: E4_LYSOPOSTTRANS – Defects in post-translational modification of lysosomal enzymes
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Defects in post-translational modification of lysosomal enzymes
↥Endpoint not on priority list, no data to show.